Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases
Abstract Lysosomal acidification dysfunction has been implicated as a key driving factor in the pathogenesis of neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease. Multiple genetic factors have been linked to lysosomal de-acidification through impairing the vacuolar-ty...
Main Authors: | Chih Hung Lo, Jialiu Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | Translational Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40035-023-00362-0 |
Similar Items
-
Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases
by: Lo, Chih Hung, et al.
Published: (2023) -
Nanomaterials-mediated lysosomal regulation: a robust protein-clearance approach for the treatment of Alzheimer’s disease
by: Mengqi Hao, et al.
Published: (2025-02-01) -
Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
by: Srinivasa Reddy Bonam, et al.
Published: (2021-12-01) -
Critical role of ROCK1 in AD pathogenesis via controlling lysosomal biogenesis and acidification
by: Chenghuan Song, et al.
Published: (2024-11-01) -
Lysosomal acidification dysfunction in microglia: an emerging pathogenic mechanism of neuroinflammation and neurodegeneration
by: Joseph D. Quick, et al.
Published: (2023-08-01)